Issue of shares to employees on conversion of options

Capital Change Notice

Updated as at June 2023



Section 1: Issuer information
Name of issuer Rua Bioscience Limited
NZX ticker code RUA
Class of financial product Ordinary Shares
ISIN (If unknown, check on NZX website) NZRUAE0004S1
Currency $NZ
Section 2: Capital change details
Number issued/acquired/redeemed 1,614,314
Nominal value (if any) n/a
Issue/acquisition/redemption price per security $nil
Nature of the payment (for example, cash or other
consideration)
Zero– provision of employment
and personal services to the
Issuer.
Amount paid up (if not in full) Fully paid
Percentage of total class of Financial Products
issued/acquired/redeemed/ (calculated on the number of
Financial Products of the Class, excluding any Treasury Stock,
in existence)
1

1.02%
For an issue of Convertible Financial Products or Options, the
principal terms of Conversion (for example the Conversion
price and Conversion date and the ranking of the Financial
Product in relation to other Classes of Financial Product) or the
Option (for example, the exercise price and exercise date)
The ordinary shares have
been issued upon the
conversion of Options granted
on 1 June 2023 in a ratio of
1:1, for NIL cash consideration,
subject to conditions set out in
Option Deeds for each
Participant dated May 2023
Reason for issue/acquisition/redemption and specific authority
for issue/acquisition/redemption/ (the reason for change must
be identified here)
The ordinary shares have
been issued upon the
conversion of Options which
were granted on 1 June 2023
in a ratio of 1:1, for NIL cash
consideration (consideration
provided was services and
performance incentive for
employees (part of
remuneration package)),
subject to conditions set out in
Option Deeds for each
Participant dated May 2023
Total number of Financial Products of the Class after the
issue/acquisition/redemption/Conversion (excluding Treasury
Stock) and the total number of Financial Products of the Class
held as Treasury Stock after the issue/acquisition/redemption.
159,750,579

1
The percentage is to be calculated immediately before the issue, acquisition, redemption or Conversion.

Capital Change Notice

Updated as at June 2023

In the case of an acquisition of shares, whether those shares
are to be held as treasury stock
n/a
Specific authority for the issue, acquisition, or redemption,
including a reference to the rule pursuant to which the issue,
acquisition, or redemption is made
Listing rules 4.6.1 and 4.11.1
and Board resolution under
which the terms of issue of the
Options were approved
Terms or details of the issue, acquisition, or redemption (for
example: restrictions, escrow arrangements)
Vesting and conversion into
ordinary shares of Options that
were granted to certain
employees on 1 June 2023 in
accordance with conditions set
out in Option Deeds for each
Participant dated May 2023.

Of the 2,100,000 Options
granted on 1 June 2023,
485,686 have lapsed in
accordance with the terms of
issue. This Notice therefore
relates to the ordinary shares
that have been issued upon
the vesting of the balance of
the Options that were
granted.
Date of issue/acquisition/redemption
2
04/06/2024
Section 3: Authority for this announcement and contact person
Name of person

authorised to make this announcement Paul Naske
Contact person for this announcement Paul Naske
Contact phone number 021445154
Contact email address Paul.naske@ruabio.com
Date of release through MAP

04/06/2024





2
Continuous issuers using this form in reliance on Rule 3.13.2, please indicate the period during which the relevant
issue/acquisition/redemptions were made (for example, 1 January 2019 to 31 January 2019).